Abstract
The goal of the study was to assess the long-term seizure and neuropsychologic outcomes of patients with tuberous sclerosis and refractory epilepsy who received vagus nerve stimulator implantation. Eleven patients with a follow-up period of at least 12 months were studied retrospectively. The mean age at the time of implantation was 14 years (range, 2-35). Seizure outcome was rated as class I (>80% seizure frequency reduction) in 1 (9%), class II (50-79% reduction) in 7 (63%), and class III (
| Original language | English |
|---|---|
| Pages (from-to) | 29-34 |
| Number of pages | 6 |
| Journal | Pediatric Neurology |
| Volume | 43 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jul 2010 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
- Pediatrics, Perinatology, and Child Health
- Developmental Neuroscience
- Neurology
Cite this
Vagus Nerve Stimulation for Refractory Epilepsy in Tuberous Sclerosis. / Zamponi, Nelia; Petrelli, Cristina; Passamonti, Claudia; Moavero, Romina; Curatolo, Paolo.
In: Pediatric Neurology, Vol. 43, No. 1, 07.2010, p. 29-34.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Vagus Nerve Stimulation for Refractory Epilepsy in Tuberous Sclerosis
AU - Zamponi, Nelia
AU - Petrelli, Cristina
AU - Passamonti, Claudia
AU - Moavero, Romina
AU - Curatolo, Paolo
PY - 2010/7
Y1 - 2010/7
N2 - The goal of the study was to assess the long-term seizure and neuropsychologic outcomes of patients with tuberous sclerosis and refractory epilepsy who received vagus nerve stimulator implantation. Eleven patients with a follow-up period of at least 12 months were studied retrospectively. The mean age at the time of implantation was 14 years (range, 2-35). Seizure outcome was rated as class I (>80% seizure frequency reduction) in 1 (9%), class II (50-79% reduction) in 7 (63%), and class III (
AB - The goal of the study was to assess the long-term seizure and neuropsychologic outcomes of patients with tuberous sclerosis and refractory epilepsy who received vagus nerve stimulator implantation. Eleven patients with a follow-up period of at least 12 months were studied retrospectively. The mean age at the time of implantation was 14 years (range, 2-35). Seizure outcome was rated as class I (>80% seizure frequency reduction) in 1 (9%), class II (50-79% reduction) in 7 (63%), and class III (
UR - http://www.scopus.com/inward/record.url?scp=77952978911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952978911&partnerID=8YFLogxK
U2 - 10.1016/j.pediatrneurol.2010.03.003
DO - 10.1016/j.pediatrneurol.2010.03.003
M3 - Article
C2 - 20682200
AN - SCOPUS:77952978911
VL - 43
SP - 29
EP - 34
JO - Pediatric Neurology
JF - Pediatric Neurology
SN - 0887-8994
IS - 1
ER -